Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 22/11/2020
SIETES contiene 93161 citas

 
 
 1 a 20 de 23 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Bafeta A, Koh M, Riveros C, Ravaud P. Harms reporting in randomized controlled trials of interventions aimed at modifying microbiota: a systematic review. Ann Intern Med 2018;169:240-7. [Ref.ID 102815]
3. Cita con resumen
Gottenberg J-E, Brocq O, Perdriger A, Lassoued S, Berthelot J-M, Wendiing D, Euller-Ziegler L, Soubrier M, Richez C, Fautrel B, Constantin AL, Mariette X, Morel J, Gilson M, Cormier G, Salmon JH, Rist S, Lioté F, Marotte H, Bonnet C, Marcelli C, Sellam J, Meyer O, Solau-Gervais E, Guis S, Ziza J-M, Zarnitsky C, Chary-Valckenaere I, Vittecoq O, Saraux A, Pers Y-M, Gayraud M, Bolla G, Glaudepierre P, Ardizzone M, Dernis E, Breban MA, Fain O, Balblanc J-C, Aberkane O, Vazel M, Back C, Candon S, Chatenoud L, Perrodeau E, Sibilia J, Ravaud P. Non-TNF-tarteged biologic vs a second anti-TNF drug to treat rheumatoid arthritis in patients with insufficient response to a first anti-TNF drug: a randomized clinical trial. JAMA 2016;316:1172-80. [Ref.ID 100753]
4. Cita con resumen
Gottenberg J-E, Ravaud P, Puéchal X, Le Guem V, Sibila J, Goeb V, Larroche C, Dubost J-J, Rist S, Saraux A, Devauchelle-Pensec V, Morel J, Hayem G, Hatron P, Perdriger A, Sene D, Zamitsky C, Bataouche D, Furlan V, Benessiano J, Perrodeau E, Seror R, Mariette X. Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial. JAMA 2014;312:249-58. [Ref.ID 97815]
5. Cita con resumen
Riveros C, Dechartre A, Perrodeau A, Haneef R, Boutron I, Ravaud P. Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals. PLOS Medicine 2013;10:e1001566. [Ref.ID 96706]
6. Cita con resumen
Dechartres A, Trinquart L, Boutron I, Ravaud P. Influence of trial sample size on treatment effect estimates: meta-epidemiological study. BMJ 2013;346:15. [Ref.ID 95533]
7. Cita con resumen
Hróbjartsson A, Thomsen ASS, Emanuelsson F, Tendal B, Hilden J, Boutron I, Ravaud P, Brorson S. Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors. BMJ 2012;344:20. [Ref.ID 92611]
9.Tiene citas relacionadas Cita con resumen
Dechartres A, Boutron I, Trinquart L, Charles P, Ravaud P. Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study. Ann Intern Med 2011;155:39-51. [Ref.ID 91363]
10. Cita con resumen
Roussel R, Travert F, Pasquet B, Wilson PWF, Smith Jr SC, Goto S, Ravaud P, Marre M, Porath A, Bhatt DL, Steg PG, for the Reduction of Atherothrombosis for Continued Health (REACH) Registry Investigators. Metformin use and mortality among patients with diabetes and atherothrombosis. Arch Intern Med 2010;170:1892-9. [Ref.ID 89701]
11. Cita con resumen
Boutron I, Dutton S, Ravaud P, Altman DG. Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA 2010;303:2058-64. [Ref.ID 88510]
12. Cita con resumen
Boutron I, Dutton S, Ravaud P, Altman DG. Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA 2010;303:2058-64. [Ref.ID 88447]
14.Tiene citas relacionadas Cita con resumen
Pitrou I, Boutron I, Ahmad N, Ravaud P. Reporting of safety results in published reports of randomized controlled trials. Arch Intern Med 2009;169:1756-61. [Ref.ID 87035]
15. Cita con resumen
Mathieu S, Boutron I, Moher D, Altman DG, Ravaud P. Comparison of registered and published primary outcomes in randomized controlled trials. JAMA 2009;302:977-84. [Ref.ID 86703]
16.
Charles P, Giraudeau B, Dechartres A, Baron G, Ravaud P. Reporting of sample size calculation in radomised controlled trials: review. BMJ 2009;338:1256-9. [Ref.ID 85969]
17. Cita con resumen
Giraudeau B, Ravaud P. Preventing bias in cluster randomised trials. PLOS Medicine 2009;6:1-6. [Ref.ID 85903]
18.Tiene citas relacionadas
Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, for the CONSORT Group. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008;148:295-309. [Ref.ID 82250]
19.Tiene citas relacionadas Cita con resumen
Le Henanff A, Giraudeau B, Baron G, Ravaud P. Quality of reporting of noinferiority and equivalence randomized trials. JAMA 2006;295:1147-51. [Ref.ID 76400]
20.
Ethgen M, Boutron I, Baron G, Giraudeau B, Sibilia J, Ravaud P. Reporting of harm in randomized, controlled trials of nonpharmacologic treatment of rheumatic disease. Ann Intern Med 2005;143:20-5. [Ref.ID 74284]
Seleccionar todas
 
 1 a 20 de 23 siguiente >>